<DOC>
	<DOC>NCT00661661</DOC>
	<brief_summary>The purpose of this study is to determine the long-term effectiveness and safety of CP-690,550 for the treatment of rheumatoid arthritis. Subjects are only eligible for this study after they have completed participation in another "qualifying" study of CP-690,550.</brief_summary>
	<brief_title>Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In Japan</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Subjects who have completed their participation in a randomized "qualifying" study of CP690,550 for the treatment of rheumatoid arthritis Serious medical conditions that would make treatment with CP690,550 potentially unsafe</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Long term open label study in Japan</keyword>
	<keyword>CP-690</keyword>
	<keyword>550</keyword>
	<keyword>tofacitinib</keyword>
</DOC>